Cameco Corporation $CCJ Shares Sold by Aubrey Capital Management Ltd

Aubrey Capital Management Ltd cut its stake in shares of Cameco Corporation (NYSE:CCJ) (TSE:CCO) by 15.0% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 36,700 shares of the basic materials company’s stock after selling 6,500 shares during the period. Cameco accounts for approximately 2.1% of Aubrey Capital Management Ltd’s holdings, making the stock its 15th biggest holding. Aubrey Capital Management Ltd’s holdings in Cameco were worth $3,987,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in the company. Sterling Capital Management LLC purchased a new stake in shares of Cameco during the 1st quarter worth about $30,000. Nisa Investment Advisors LLC purchased a new stake in Cameco during the fourth quarter worth approximately $25,000. Brown Lisle Cummings Inc. grew its stake in Cameco by 3,200.0% during the first quarter. Brown Lisle Cummings Inc. now owns 297 shares of the basic materials company’s stock worth $32,000 after buying an additional 288 shares during the period. Founders Capital Management purchased a new stake in Cameco during the fourth quarter worth approximately $27,000. Finally, Mcguire Capital Advisors Inc. acquired a new stake in shares of Cameco in the fourth quarter worth $28,000. 70.21% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Cameco

Here are the key news stories impacting Cameco this week:

• Positive Sentiment: Some analysts remain constructive on Cameco, pointing to strong uranium production, diversification from Westinghouse and Fuel Services, and a high price target that implies meaningful upside. Cameco Q2 Preview: Earnings Could Restart The Nuclear Rally
• Neutral Sentiment: Coverage comparing Cameco with Energy Fuels argued that CCJ is a weaker uranium opportunity today, though the view was based more on relative fundamentals than a fresh company-specific event. UUUU vs. CCJ: Which Uranium Stock Offers the Better Opportunity Today?
• Neutral Sentiment: A Seeking Alpha article also argued that Wall Street may be paying too much for Cameco’s long-term nuclear growth story, adding to the debate around valuation rather than changing the underlying business outlook. Cameco: Wall Street Is Paying Too Much For A Nuclear Dream
• Negative Sentiment: Investor concern increased after Cameco’s temporary Cigar Lake mining suspension, which raised questions about near-term production reliability and helped push the stock lower. Cameco Falls as Investors Weigh Mine Disruption and Softer Uranium Sentiment
• Negative Sentiment: Unusual trading in CCJ put options suggests traders were positioning for more downside, reinforcing the cautious tone around the stock.

Cameco Trading Up 1.6%

NYSE CCJ opened at $91.68 on Wednesday. The company’s fifty day simple moving average is $105.73 and its 200-day simple moving average is $110.91. Cameco Corporation has a 52 week low of $68.96 and a 52 week high of $135.24. The company has a current ratio of 3.08, a quick ratio of 2.09 and a debt-to-equity ratio of 0.14. The stock has a market cap of $39.93 billion, a P/E ratio of 84.89, a PEG ratio of 1.59 and a beta of 1.02.

Cameco (NYSE:CCJ) (TSE:CCO) last announced its earnings results on Tuesday, May 5th. The basic materials company reported $0.34 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.05. The business had revenue of $607.49 million during the quarter, compared to the consensus estimate of $598.63 million. Cameco had a net margin of 18.38% and a return on equity of 11.05%. The business’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.16 earnings per share. Equities research analysts predict that Cameco Corporation will post 1.2 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

CCJ has been the topic of a number of research reports. TD Securities downgraded shares of Cameco from a “strong-buy” rating to a “hold” rating in a research note on Thursday, March 26th. Truist Financial initiated coverage on shares of Cameco in a research report on Monday. They set a “buy” rating and a $129.00 price target for the company. Scotiabank reiterated an “outperform” rating and issued a $175.00 price target on shares of Cameco in a report on Wednesday, May 6th. Barclays started coverage on Cameco in a research report on Thursday, May 21st. They issued an “equal weight” rating and a $108.00 price objective on the stock. Finally, Sanford C. Bernstein restated an “outperform” rating and set a $135.00 price objective on shares of Cameco in a research note on Monday, June 15th. Thirteen research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $146.52.

About Cameco

Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.

The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.